Artemis Therapeutics Inc (ATMS) Company Profile

Artemis Therapeutics Inc Company Snapshot

Artemis Therapeutics Inc operates in the Investment offices sector. In addition to historical fundamental analyses, the complete report available to purchase compares Artemis Therapeutics Inc with three other companies in this sector in UNITED STATES : Gabelli Global Small and Mid Cap Value Trust (2014 sales of $328,983.00 ), Sunstock Inc ($166,492.00 ), and Millennium Investment & Acquisition Company Inc ($415,124.00 ).

Sales Analysis. Sales fell dramatically in 2014: Artemis Therapeutics Inc reported sales of $244,000.00 for the year ending December of 2014. This represents a sharp decrease of 81.1% versus 2013, when the company's sales were $1.29 million.

Stock Performance Chart for Artemis Therapeutics Inc

Stock Data:

Recent Stock Performance:

Current Price (2/19/2021): .52
(Figures in U.S. Dollars)

1 Week	-1.3%	13 Weeks	243.5%

4 Weeks	146.0%	52 Weeks	n/a

Artemis Therapeutics Inc Key Data:

Ticker:	ATMS	Country:	United States

Exchanges:	OTC	Major Industry:	Diversified Financials

		Sub Industry:	Investment Offices

2014 Sales	244,000 (Year Ending Jan 2015).	Employees:	13

Currency:	U.S. Dollars	Market Cap:	2,674,646

Fiscal Yr Ends:	December	Shares Outstanding:	5,153,461

Share Type:	Common	Closely Held Shares:	3,501,307

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.